scispace - formally typeset
P

Peter Lindgren

Researcher at Karolinska Institutet

Publications -  216
Citations -  8039

Peter Lindgren is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Cost effectiveness & Population. The author has an hindex of 41, co-authored 189 publications receiving 7299 citations. Previous affiliations of Peter Lindgren include Karolinska University Hospital & Uppsala University.

Papers
More filters
Journal ArticleDOI

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

TL;DR: Guidelines and Expert Consensus documents aim to present management and recommendations based on all of the relevant evidence on a particular subject in order to help physicians to select the best possible management strategies for the individual patient, suffering from a specific condition, taking into account not only the impact on outcome, but also the risk benefit ratio of a particular diagnostic or therapeutic procedure.
Journal ArticleDOI

Costs and quality of life of patients with multiple sclerosis in Europe

TL;DR: Overall resource consumption, work capacity and quality of life of patients with multiple sclerosis in nine European countries was assessed, and Informal care use was highly correlated with disease severity, but was further influenced by healthcare systems and family structure.
Journal ArticleDOI

Gender differences in smoking cessation after 3 years in the Lung Health Study.

TL;DR: Demographics and smoking history were more important than gender per se in sustained smoking cessation in the Lung Health Study and programs tailoring smoking cessation by gender need to include coping skills for problems associated with less education and social support and for improving persistence with quit attempts.
Journal ArticleDOI

Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation

TL;DR: Estimates of the economic burden posed by AF are critical in light of the increasing importance of AF as a public health problem, and accounting for more than 70% of total annual costs in all five countries.
Journal ArticleDOI

Costs and quality of life in multiple sclerosis

TL;DR: All types of costs increased with increasing disability, while utilities decreased, a cross-sectional, “bottom-up” observational study of resource use, costs, and quality of life in patients with multiple sclerosis in Germany.